版本:
中国

BRIEF-Mirna therapeutics' investigational new drug for MRX34 has been placed on full clinical hold

Sept 29 Mirna Therapeutics Inc

* Investigational new drug for MRX34, investigational Microrna Therapy for multiple cancers, has been placed on full clinical hold

* Anticipates that it will receive a formal clinical hold letter from FDA within 30 days - SEC filing Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐